tiprankstipranks
Trending News
More News >
Igm Biosciences (IGMS)
:IGMS
US Market
Advertisement

IGM Biosciences (IGMS) Price & Analysis

Compare
Followers

IGMS Stock Chart & Stats


IGM Biosciences News

IGMS FAQ

What was Igm Biosciences’s price range in the past 12 months?
Currently, no data Available
What is Igm Biosciences’s market cap?
Currently, no data Available
When is Igm Biosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Igm Biosciences’s earnings last quarter?
Currently, no data Available
Is Igm Biosciences overvalued?
According to Wall Street analysts Igm Biosciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does Igm Biosciences pay dividends?
    Igm Biosciences does not currently pay dividends.
    What is Igm Biosciences’s EPS estimate?
    Igm Biosciences’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Igm Biosciences have?
    Currently, no data Available
    What happened to Igm Biosciences’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Igm Biosciences?
    Currently, no hedge funds are holding shares in IGMS

    Company Description

    Igm Biosciences

    IGM Biosciences, Inc. is a biotechnology company focused on developing innovative therapies based on its proprietary IgM antibody platform. Founded in 2010, the company operates primarily in the biopharmaceutical sector, concentrating on the design and commercialization of novel therapeutics for the treatment of various cancers and autoimmune diseases. Its core products include IGM-2323, an investigational IgM antibody designed to target specific cancer cells, as well as other pipeline candidates aimed at addressing unmet medical needs.

    IGM Biosciences (IGMS) Earnings & Revenues

    Currently, no data available
    Please return soon. This page is being updated.
    Similar Stocks
    Company
    Price & Change
    Follow
    ImmunoPrecise Antibodies
    Surrozen
    Adagene
    Alto Neuroscience, Inc.
    Metagenomi, Inc.

    Ownership Overview

    4.62%6.76%49.57%36.29%
    4.62%
    Insiders
    49.57% Other Institutional Investors
    36.29% Public Companies and
    Individual Investors

    Options Prices

    Currently, No data available
    ---
    Popular Stocks
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis